The anti-VEGF drug, Avastin® (bevacizumab), was used to treat patients with diabetic macular edema. The study found that over 50% of patients receiving the drug noted improved vision. Overall, 97% of patients were either stabilized or noted improvement over the two year study period. In...
Elevated Hg A1C and Lipoprotein A may lead to progression of non-proliferative diabetic retinopathy....
What constitutes a diabetic eye exam? An annual check, at the very least, is required to look for signs of diabetic retinopathy. Early detection can save your sight....
Diabetic Macular Edema is also treated successfully with sub-tenon's injection of steroid...
Diabetics need regular annual eye exams regardless of symptoms. Diabetic retinopathy can cause no symptoms, blurry vision or blindness....
Dexamethsone steroid device has immediate implications for the treatment of diabetic macular edema....
Sugar control is not the key to preventing diabetic retinopathy....
A five year prospective study reveals that insulin glargine is as safe as NPH insulin with regard to developing diabetic retinopathy. Patients placed on insulin glargine are no more likely to develop diabetic retinopathy than Type II diabetics on NPH insulin. The study also...
Cost efficient method of screening for diabetic retinopathy is described. ...